|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Altimmune, Inc.
| | | Phone: | (410) 269-2600 | Fax: | (410) 269-2601 | Year Established: | 1997 | Ticker: | ALT | Exchange: | NASDAQ | Main Contact: | Elizabeth A. Czerepak, CFO & Executive VP, Corporate Development | | Other Contacts: | Elizabeth A. Czerepak, CFO & Ececutive VP, Corporate Development Bertrand Georges, Ph.D., CTO Sybil Tasker, M.D., FACP, FIDSA, Senior VP, Clinical Research and Development Bill Enright, CEO Scot Roberts, Ph.D., CSO
| | Company Description | Altimmune, formerly PharmAthene and Vaxin, is a clinical stage immunotherapeutics biotechnology company that is leveraging the complementary attributes of its two innovative vaccine delivery platforms, RespirVec™ and Densigen™, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including acute respiratory infections, chronic viral infections and cancer, with the potential for fundamental advantages over competing products. | |
|
|
|
|
|